Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fractures After Denosumab Discontinuation: A Retrospective Study of
797
Cases
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-05-20
DOI
10.1002/jbmr.4335
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Single Infusion of Zoledronate in Postmenopausal Women Following Denosumab Discontinuation Results in Partial Conservation of Bone Mass Gains
- (2020) Judith Everts‐Graber et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports
- (2019) O. Lamy et al. OSTEOPOROSIS INTERNATIONAL
- Stopping Denosumab
- (2019) Olivier Lamy et al. Current Osteoporosis Reports
- Spontaneous vertebral fractures after denosumab discontinuation: A case collection and review of the literature
- (2019) Helena Florez et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Spontaneous Vertebral Fractures in Males with Osteoporosis After Denosumab Discontinuation
- (2019) Panagiotis Anagnostis et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Effect of Zoledronate on Bone Loss After Romosozumab/Denosumab: 2-Year Follow-up
- (2019) Anne M. Horne et al. CALCIFIED TISSUE INTERNATIONAL
- Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2‐year Clinical Trial
- (2019) Athanasios D. Anastasilakis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Hip fractures following denosumab discontinuation: three clinical cases reports
- (2019) Manuel Sosa Henríquez et al. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
- Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors
- (2019) Elena Gonzalez-Rodriguez et al. BREAST CANCER RESEARCH AND TREATMENT
- Bone Mineral Density After Transitioning From Denosumab to Alendronate
- (2019) David Kendler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fracture incidence after denosumab discontinuation: Real-world data from a large healthcare provider
- (2019) Liana Tripto-Shkolnik et al. BONE
- Vertebral Fractures Following Denosumab Discontinuation in Patients with Prolonged Exposure to Bisphosphonates
- (2018) Liana Tripto-Shkolnik et al. CALCIFIED TISSUE INTERNATIONAL
- Underestimation of Vertebral Fractures After Denosumab Discontinuation
- (2018) Olivier Lamy et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment
- (2017) Athanasios D Anastasilakis et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
- (2017) Athanasios D Anastasilakis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates
- (2017) B. Uebelhart et al. OSTEOPOROSIS INTERNATIONAL
- Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures
- (2017) T. Lehmann et al. OSTEOPOROSIS INTERNATIONAL
- Observations following discontinuation of long-term denosumab therapy
- (2017) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study
- (2017) M. B. Zanchetta et al. OSTEOPOROSIS INTERNATIONAL
- Severe rebound-associated vertebral fractures after denosumab discontinuation: nine clinical cases report
- (2016) Olivier Lamy et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort
- (2016) I. Padlina et al. OSTEOPOROSIS INTERNATIONAL
- Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports
- (2015) B. Aubry-Rozier et al. OSTEOPOROSIS INTERNATIONAL
- Multiple clinical vertebral fractures following denosumab discontinuation
- (2015) A. D. Anastasilakis et al. OSTEOPOROSIS INTERNATIONAL
- Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics
- (2015) A. W. Popp et al. OSTEOPOROSIS INTERNATIONAL
- Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial
- (2012) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone remodeling in postmenopausal women who discontinued denosumab treatment: Off-treatment biopsy study
- (2011) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vertebral fracture assessment using a semiquantitative technique
- (2010) Harry K. Genant et al. JOURNAL OF BONE AND MINERAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now